NYSE:BME BlackRock Health Sciences Trust (BME) Stock Forecast, Price & News $38.76 +0.26 (+0.68%) (As of 09:55 AM ET) Add Compare Share Share Today's Range$38.52▼$38.7650-Day Range$38.50▼$40.3152-Week Range$38.37▼$45.50Volume3,844 shsAverage Volume29,467 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield6.58%Price TargetN/A ProfileProfileChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About BlackRock Health Sciences Trust (NYSE:BME) StockBlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.Read More BME Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BME Stock News HeadlinesSeptember 20, 2023 | msn.comBME: A Discounted Opportunity In The Healthcare SpaceJuly 14, 2023 | finance.yahoo.comBME - BlackRock Health Sciences TrustOctober 4, 2023 | Edge On The Street (Ad)The Strategic Gold Play You Haven't Heard AboutExperts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. July 8, 2023 | wsj.comBlackRock Health Sciences Opportunities Portfolio;Investor AApril 5, 2023 | msn.comBlackRock Health Sciences Trust (BME) Declares $0.21 DividendNovember 14, 2022 | seekingalpha.comBlackRock Health Sciences Trust goes ex-dividend on MondayOctober 15, 2022 | fool.comBlackrock Health Sciences Trust (NYSE: BME)August 9, 2022 | apnews.comHealth care providers suing Blue Cross/Blue Shield for antitrust violations obtain ruling that strengthens their caseOctober 4, 2023 | Wall Street Fundamentals (Ad)Would Buffett Approve of This Growth Strategy?Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.May 12, 2022 | seekingalpha.comBlackRock Health Sciences Trust goes ex-dividend tomorrowApril 11, 2022 | nasdaq.comEx-Dividend Reminder: BlackRock Health Sciences Trust II, BankUnited and American Financial GroupApril 6, 2022 | finance.yahoo.comWe're Interested To See How Black Mountain Energy (ASX:BME) Uses Its Cash Hoard To GrowMarch 5, 2022 | seekingalpha.comBlackRock Health Sciences Trust declares $0.213 dividendFebruary 28, 2022 | finance.yahoo.comOvid Pharmaceuticals CEO details biotech pledge to cut ties with RussiaJanuary 29, 2021 | seekingalpha.com7% Discount, 4% Yield, Next-Generation Healthcare: BlackRock Health Sciences Trust IIJuly 10, 2020 | www.nasdaq.comEx-Dividend Reminder: Franklin Resources, BlackRock Health Sciences Trust II and OracleApril 13, 2020 | seekingalpha.comBlackRock Health Sciences Trust II goes ex-dividend tomorrowFebruary 14, 2020 | ca.finance.yahoo.comBlackRock Health Sciences Trust (BME)June 28, 2019 | seekingalpha.comBME: Large-Cap Healthcare Exposure Rolled Into One CEFJune 6, 2019 | finance.yahoo.com8 U.K. stocks for contrarian U.S. investorsMarch 19, 2019 | www.thestreet.comBlackrock Health Sciences TrustSee More Headlines Receive BME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address BME Company Calendar Ex-Dividend for 8/31 Dividend8/14/2023Dividend Payable8/31/2023Ex-Dividend for 9/29 Dividend9/14/2023Dividend Payable9/29/2023Today10/04/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Asset Management Sub-IndustryN/A SectorFinancial Services Current SymbolNYSE:BME CUSIPN/A CIK1314966 Webwww2.blackrock.com Phone(800) 882-0052FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$47.58 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Charles Choon Sik Park (Age 56)Chief Compliance Officer and Anti-Money Laundering Officer Mr. Thomas P. Callan C.F.A.Portfolio Mang.Mr. Kyle G. McClements C.F.A.CFA, Portfolio Mang.Dr. Erin Xie Ph.D. (Age 55)Portfolio Mang. Mr. Christopher M. AccettellaPortfolio Mang.Mr. Jeffrey Gene LeePortfolio Mang.Dr. Xiang Liu Ph.D.Portfolio Mang.More ExecutivesKey Competitorsabrdn Global Premier Properties FundNYSE:AWPAbrdn Income Credit Strategies FundNYSE:ACPAdvent Convertible and Income FundNYSE:AVKAllianceBernstein National Municipal Income FundNYSE:AFBApollo Senior Floating Rate FundNYSE:AFTView All CompetitorsInstitutional OwnershipOsaic Holdings Inc.Sold 53,225 shares on 8/21/2023Ownership: 0.000%Wells Fargo & Company MNSold 25,890 shares on 8/15/2023Ownership: 0.000%Royal Bank of CanadaBought 2,110 shares on 8/15/2023Ownership: 0.000%Stifel Financial CorpSold 9,120 shares on 8/15/2023Ownership: 0.000%Kestra Advisory Services LLCBought 6,726 shares on 8/11/2023Ownership: 0.000%View All Institutional Transactions BME Stock - Frequently Asked Questions How have BME shares performed in 2023? BlackRock Health Sciences Trust's stock was trading at $43.58 on January 1st, 2023. Since then, BME stock has decreased by 11.7% and is now trading at $38.50. View the best growth stocks for 2023 here. Are investors shorting BlackRock Health Sciences Trust? BlackRock Health Sciences Trust saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 15,300 shares, an increase of 135.4% from the August 31st total of 6,500 shares. Based on an average daily trading volume, of 31,000 shares, the days-to-cover ratio is currently 0.5 days. View BlackRock Health Sciences Trust's Short Interest. How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust? BlackRock Health Sciences Trust declared a monthly dividend on Friday, September 1st. Stockholders of record on Friday, September 15th will be given a dividend of $0.213 per share on Friday, September 29th. This represents a $2.56 annualized dividend and a dividend yield of 6.64%. The ex-dividend date of this dividend is Thursday, September 14th. Read our dividend analysis for BME. Is BlackRock Health Sciences Trust a good dividend stock? BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.55 per share and currently has a dividend yield of 0.06%. Read our dividend analysis for BME. What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO? 3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of BlackRock Health Sciences Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG). What is BlackRock Health Sciences Trust's stock symbol? BlackRock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME." How do I buy shares of BlackRock Health Sciences Trust? Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BlackRock Health Sciences Trust's stock price today? One share of BME stock can currently be purchased for approximately $38.50. How can I contact BlackRock Health Sciences Trust? BlackRock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The official website for the company is www2.blackrock.com. The company can be reached via phone at (800) 882-0052. This page (NYSE:BME) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BlackRock Health Sciences Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.